Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

To compare the pharmacokinetics of single chain recombinant factor VIII with full length recombinant factor VIII in patients with severe haemophilia A

Trial Profile

To compare the pharmacokinetics of single chain recombinant factor VIII with full length recombinant factor VIII in patients with severe haemophilia A

Completed
Phase of Trial: Phase I

Latest Information Update: 17 Mar 2017

At a glance

  • Drugs Octocog alfa (Primary)
  • Indications Haemophilia A
  • Focus Pharmacokinetics
  • Most Recent Events

    • 17 Mar 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top